Group items tagged

The Epilepsy Foundation has announced its eighth annual epilepsy "Shark Tank" competition for the most innovative ideas in epilepsy and seizure treatment and care. Examples of novel ideas include a system to detect seizures with the capacity to provide early warning to the patient or family; a treatment that stops a seizure from progressing; a system that helps patients manage their daily treatment; a device that prevents physical injury that patients may experience when in seizure; or an entirely new product concept with the promise to dramatically improve the lives of people with epilepsy. Selected finalists will receive international recognition and compete for grants totaling $200,000 to support the development and commercialization of their new product, technology, or therapeutic concept. As many as six finalists will be selected to present at the 2019 Anti-Epileptic Drug & Device Trials, May 22-24, 2019, in Miami. Each presenter will have five minutes to present the concept, followed by five minutes of questioning. The event will feature live voting among audience members and a panel of judges (Sharks) representative of industry, advocacy, investors, and the research and medical communities. The project (or projects) deemed to be the most innovative will be announced at the conclusion of the competition. 

The Epilepsy Foundation has announced its seventh annual epilepsy "Shark Tank" competition for the most innovative ideas in epilepsy and seizure treatment and care. Some examples of novel ideas include a system to detect seizures with the capacity to provide early warning to the patient or family; a treatment that stops a seizure from progressing; a system that helps patients manage their daily treatment; a device that prevents physical injury that patients may experience when in seizure; or an entirely new product concept with the promise to dramatically improve the lives of people with epilepsy. Selected finalists will receive international recognition and compete for grants totaling $150,000 to support the development and commercialization of important new products, technologies, or therapeutic concepts. As many as six finalists will be selected to present at the 2018 Epilepsy Pipeline Conference (San Francisco, February 22-23, 2018). Each presenter will have five minutes to present the concept, followed by five minutes of questioning. The Shark Tank event will feature live voting among audience members and a panel of judges (Sharks) representative of industry, advocacy, investors, and the research and medical communities. The winning project, or projects, deemed to be the most innovative will be announced at the conclusion of the competition. To be eligible, applicants must demonstrate an ability to move the proposed plan to completion, showing how the prize can accelerate any step along the path to market. Inventors who submitted ideas for previous Shark Tank competitions are encouraged to re-submit their ideas if substantial progress has been made.

The Epilepsy Foundation has announced its seventh annual epilepsy "Shark Tank" competition for the most innovative ideas in epilepsy and seizure treatment and care. Selected finalists will receive international recognition and compete for grants totaling $150,000 to support the development and commercialization of important new products, technologies, or therapeutic concepts. As many as six finalists will be selected to present at the 2018 Epilepsy Pipeline Conference (San Francisco, February 22-23, 2018). Each presenter will have five minutes to present the concept, followed by five minutes of questioning. The event will feature live voting among audience members and a panel of judges (Sharks) representative of industry, advocacy, investors, and the research and medical communities. The winning project(s) deemed to be the most innovative will be announced at the conclusion of the competition. To be eligible, applicants must demonstrate an ability to move the proposed plan to completion, showing how the prize can accelerate any step along the path to market. Inventors who submitted ideas in previous Shark Tank competitions are encouraged to re-submit their ideas if substantial progress has been made.

The Orphan Disease Center works with closely with community organizations, the biotech community, and researchers to improve therapeutic treatment options for those afflicted with orphan diseases. Oftentimes genetic, orphan diseases are conditions that affect fewer than two hundred thousand individuals nationwide. Due to their relative rarity, research and funding for these conditions is largely unmet. In support of this mission, the center has partnered with the LouLou Foundation, a pioneer in CDKL5 research, and is accepting applications for the CDKL5 Program of Excellence Pilot Grant Program. Through the program, grants of up to $150,000 will be awarded in support of research focused on treatments for CDKL5 Deficiency Disorder. Those with CDD suffer from treatment-resistant seizures, severe cognitive and motor disability, as well as sensory problems. Because there are many knowledge gaps in CDKL5 research, the foundation is interested in any basic research with the potential to contribute to future treatment options. Priority areas established by the foundation include innovative therapeutic approaches for CDD, systems biology and computational modeling approaches, novel applications of functional techniques, and discovery and validation of CDKL5 biomarkers.